Applied uv continues to expand intellectual portfolio with additional patent grant

Receives patents for pathogen destroying device in hong kong, china adds to company's portfolio of patents for disinfection technology addressing global challenge of controlling the spread of emerging pathogens mount vernon, ny / accesswire / january 18, 2022 / applied uv, inc. (nasdaqcm:auvi) ("applied uv" or the "company"), a pathogen elimination technology company that applies the power of narrow-range ultraviolet light ("uvc") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, today announced the continued expansion of its intellectual property ("ip") portfolio. applied uv, through its recent acquisitions, (airocide, kes science and technology and scientific air management) owns a broad and growing patent portfolio for its surface and air pathogen sterilization platforms in the areas of healthcare, hospitality, commercial and municipal markets.
AUVI Ratings Summary
AUVI Quant Ranking